Oxygen Therapy for Retinal Ischemia

Beth Israel Lahey Health

Status and phase: Withdrawn; Phase 4

Conditions: Retinal Ischemia

Treatments: Drug: Hyperoxia

Study type: Interventional

Funder types: Other

Identifiers

NCT03730779

Trials2018

Details and patient eligibility

About

The investigators will be using nocturnal normobaric hyperoxia therapy in patients with diagnoses of conditions related to retinal ischemia.

Full description

Patients who receive a diagnosis of a condition relate to retinal ischemia and who pass the eligibility criteria will receive an oxygen concentrator to use at home. They will report back in follow up monthly for three to six months.

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Diagnosis of retinal-ischemia related condition

Exclusion criteria

• Complicating other ocular condition
• History of smoking or lung conditions

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

0 participants in 1 patient group

O2 recieving

Experimental group

Description:

Patients who receive hyperoxia

Treatment:

Drug: Hyperoxia